|Cell line name||haNK|
|Synonyms||high affinity NK; CD16-V158.NK-92.05|
|Resource Identification Initiative||To cite this cell line use: haNK (RRID:CVCL_IM23)|
|Comments||Characteristics: No longer dependent on IL2.|
Transfected with: HGNC; 3619; FCGR3A (with p.Phe176Val).
Transfected with: HGNC; 6001; IL2.
Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers for this cell line. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
Derived from sampling site: Peripheral blood. Cell type=Natural killer cell.
|Disease||Natural killer cell lymphoblastic leukemia/lymphoma (NCIt: C82217)|
|Species of origin||Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|Hierarchy||Parent: CVCL_2142 (NK-92)|
|Sex of cell||Male|
|Age at sampling||50Y|
|Category||Cancer cell line|
|Encyclopedic resources||Wikidata; Q54872409|
|Last entry update||16-Dec-2021|